Tabula Rasa HealthCare — Merger or Acquisition (March 2019)
10 slides from Tabula Rasa HealthCare's merger presentation, Mar 5, 2019
Slide 1: Legal Disclosure: Forward-looking statements
Legal Disclosure Forward-looking statements This presentation contains “forward-looking” statements that are based on our management’s beliefs and assumptions and on information currently available to management. Forward-looking statements as defined by the Private Securities Litigation Reform Act o
Slide 2: Transaction Terms
Transaction Terms $150 million cash Price Transaction closed March 5, 2019 Timing Cash portion will be funded from the balance sheet Financing
Slide 3: PrescribeWellness at a Glance
PrescribeWellness at a Glance PrescribeWellness works with over 10,000 community pharmacies across the U.S., Canada, and Puerto Rico to support them as they expand their role and provide enhanced services to improve patient medication adherence, loyalty, and health outcomes. Community pharmacies aro
Slide 4: Strategic Rationale
Strategic Rationale Expands the addressable market to include pharmacies and pharma development Bolsters MTM offering with the addition of a community pharmacy engagement tool Offers a highly scalable solution to support EMTMs expansion into community pharmacies Accelerates development efforts and r
Slide 5: Unique and Expansive Patient Reach & Footprint
Unique and Expansive Patient Reach & Footprint Community Pharmacies 10k+ Patients in the Network Patients within 5 miles of a PW Pharmacy 277M 40M Medicare-Eligible Patients 10M Pharmacy Management System and EMR Integrations 90+ SELECT PARTNERS
Slide 6: Highly Scalable Technology Platform
Highly Scalable Technology Platform 7 PATIENT ENGAGEMENT PLATFORM (APIs) The Patient Engagement Platform ingests and transforms multiple data sets to create a holistic view of the patient, empowering engagement, 3rd party integrations and rapid application development. Behaviors Medication Health SM
Slide 7: Financial Rationale
Financial Rational Strong visibility and highly recurring revenue Attractive gross margin profile in the high 70% range EBITDA positive in 2018 and targeting +20% margins at scale Cross-sell PW’s care campaigns to Tabula Rasa customers Cross-sell Medication Safety Score to PW customers PrescribeWell
Slide 8: PrescribeWellness Historical and Expected Financials
PrescribeWellness Historical and Expected Financials $23.6 $29.0 ~ $35.0 2017 2018 2019E Revenue ($M) ($0.6) $0.3 ~ $5.0 2017 2018 2019E EBITDA ($M) 77.5% 78.8% 79.2% 2016 2017 2018 Gross Margin % 6,466 7,469 9,358 2016 2017 2018 Number of Pharmacy Locations
Slide 9: Updated 2019 Outlook
Updated 2019 Outlook Revenue Adjusted EBITDA Net Income (Loss) Previous 1Q19 Guidance Updated 1Q19 Guidance Previous 2019 Guidance Updated 2019 Guidance $55.0m - $60.0m $57.0m - $62.0m $250m - $260m $280m - $290m ($6.1)m – ($5.3)m ($6.1)m – ($5.3)m ($12.9)m – ($9.2)m ($12.9)m – ($9.2)m $4.0m - $5.0m
Slide 10: Updated 2019 Outlook
Updated 2019 Outlook Previous Updated Previous Updated 2019 Guidance Revenue $55.0m -$60.0m —$57.0m - $62.0m $250m - $260m. $280m - $290m. Net Income laws ($6.1)m—($5.3)m — ($6.1)m - ($5.3)m ($12.9)m —($9.2)m ($12.9) — ($9.2)m $4.0m - $5.0m $4.0m - $5.0m $32.0m -$37.0m — $36.0m - $41.0m 1Q19 1Q19 Gu
Tabula Rasa HealthCare — Merger or Acquisition (March 2019) on 6ix